Health
Ukraine war: Kyiv transforms surgical hospital into battleground medical facility
NEWNow you can hearken to Fox Information articles!
Russia’s bloody invasion of Ukraine has pressured the workers to rework Kyiv’s largest hospital, Medical Hospital #8, right into a battleground medical facility, in accordance with a current Wall Road Journal report.
Dermatologists and cardiologists now help with triaging wounded sufferers arriving from artillery and rocket barrages because the hospital sits inside 10 miles of the battleground, the paper famous.
The workers are numb to the air raid sirens as a result of they’re so frequent to take significantly anymore, and don’t put on face masks due to the fixed background noise of combating as they attempt to discuss to speak, per the Journal.
“In fact we’re not what we was, however neither is the remainder of the nation,” stated Dr. Igor Khomenko, the hospital director.
He labored for 30 years as a army surgeon, however give up earlier this 12 months to turn into a civilian, but his hope for a quiet civilian life was dashed when two weeks after he give up the army, the Russian invasion started, per the Journal.
BIDEN’S IMPULSIVE WORDS CONTINUE TO TERRIFY INSTEAD OF CONSOLE US
“I attempted civilian life and it didn’t final lengthy,” he famous, who now sleeps on a sofa in his workplace away from his spouse who has taken refuge far-off from the battlefield.
He lowered his hospital workers by half and canceled elective surgical procedures, so 200 hospital beds can be free for sufferers wounded by the conflict, the paper stated.
The hospital instances are a window into conflict ways as they evolve – initially they have been primarily gunshot wounds as gun battles rage, however because the conflict has progressed, extra sufferers are arriving with shrapnel wounds and concussions, as each side undergo from blast explosions from a distance, in accordance with the information report.
However regardless that the hospital’s location is so near the combating, Khomenko notes it has one benefit – the wounded can go immediately from the battlefield to the working room.
This bypasses the standard manner the wounded are handled in conflict, the place often they first get handled on the battlefield as combating continues, then cell area hospitals whereas they await their alternative to be transported to a surgical hospital for definitive care.
Khomenko describes one case: After a person was shot by means of the guts, the hospital workers saved his life by cracking his chest open and stitching the outlet shut earlier than the affected person may bleed to demise.
He advised the paper he operated on the person and plugged the outlet in his coronary heart along with his personal index finger whereas it continued to pump to ensure the person didn’t bleed out.
Just lately the Journal reported one other instance of Ukrainians struggling because of the unprovoked invasion. After the glass home windows of the hospital shook from a big thud from a Russian missile, aged civilians with bloody faces quickly wobbled to the hospital entrance, with bandages on their heads.
RUSSIA, UKRAINE TO RESUME IN-PERSON TALKS AFTER BIDEN’S OVERSEAS GAFFES ON TROOPS IN UKRAINE, PUTIN’S ‘POWER’
After nurses helped the sufferers launch their padded jackets as items of glass hidden in folds of their clothes pierced the ground, they wheeled them to the working room on metal gurneys, the place medical doctors painstakingly used tweezers to take away the shards of glass out of 1 man’s face, arms and buttocks, all whereas the affected person lay on his abdomen, clenching his fist in agony.
But it surely wasn’t over. The injuries then needed to be stitched up, the paper famous.
“They inform me to return again to Gaza, that Ukraine is simply too harmful,” stated Dr. Makhmud Akmad, the hospital’s main vascular surgeon who was born in Gaza, however got here to Ukraine to review drugs and stayed after assembly a fellow pupil who he later married.
“I inform them that I’ll keep right here, Ukraine is my dwelling now.”
Health
The Anti-Inflammatory and Mediterranean Diets: Two Immune System-Boosting Diets That Don't Skimp on Flavor | Woman's World
Sign Up
Create a free account to access exclusive content, play games, solve puzzles, test your pop-culture knowledge and receive special offers.
Already have an account? Login
Forgot your password?
Get back to the Sign In
Use left and right arrow keys to navigate between menu items.
Use escape to exit the menu.
Health
New Parkinson's drug could slow or reverse progression of disease, researchers say: 'Big step forward'
A new drug is being tested to relieve Parkinson’s disease (PD) symptoms – and it’s reportedly showing promise.
The drug is designed to slow or halt the progression of the disease in patients by targeting toxic proteins that build up in the brain, according to the study published in the journal Nature Medicine on June 20.
Researchers conducted a phase 1 placebo-controlled trial of an investigational immunotherapy drug called UB-312, testing for safety, tolerability and immunogenicity (strength of immune response).
AI BLOOD TEST COULD DETECT PARKINSON’S DISEASE UP TO 7 YEARS BEFORE SYMPTOMS: ‘PARTICULARLY PROMISING’
The trial results showed that the drug was generally safe and well-tolerated by patients as a disease-modifying treatment for Parkinson’s.
The researchers stated that to their knowledge, this is the first report showing a positive effect of an investigational therapy of this kind.
There is currently no cure for Parkinson’s, only drugs that treat the symptoms.
“UB-312 is designed to modify the course of Parkinson’s disease by targeting the underlying cause,” Lou Reese, co-founder of Vaxxinity, the Texas-based pharmaceutical company that worked on the study, told Fox News Digital.
Leiden University Medical Centre in the Netherlands, University of Texas McGovern Medical School, and Mayo Clinic in Rochester, Minnesota, also helped conduct the study.
MILITARY VETERAN EMBRACES ‘NEW SERVICE’ OF HELPING OTHERS AFTER HIS PARKINSON’S DIAGNOSIS: ‘THERE IS HOPE’
“In our phase 1 trial, we showed that UB-312 may be able to stop or even reverse the course of disease by successfully targeting aggregated alpha-synuclein.”
(Alpha-synuclein is an acidic protein that builds up in the brains of Parkinson’s patients.)
UB-312 is given as an injection, typically via multiple doses over several months, Reese noted.
“Time and science will help us to determine if this newer approach will fare better.”
During the trial, PD patients reported improved daily movement after receiving the new drug.
The medication was found to be safe and well-tolerated in healthy people and Parkinson’s patients alike, with only minimal side effects that included headaches and fatigue, according to Reese.
UB-312 works by targeting the “harmful Parkinson’s protein” alpha-synuclein and producing antibodies against it, the researcher said.
In the trial, 12 out of 13 patients developed antibodies, which Reese described as a “big step forward in PD treatment.”
RESEARCHERS FIND SOURCES OF FOUR BRAIN DISORDERS, WHICH COULD LEAD TO NEW TREATMENTS
“These antibodies reached the brain and interacted with the target protein,” he said.
Based on the “promising” results of Phase 1, UB-312 will now progress into phase 2 trials, focusing on a larger patient population while optimizing the dose, according to Reese.
“The ultimate goal is to develop effective, disease-modifying treatments that can improve outcomes and provide hope for individuals living with Parkinson’s disease,” he added.
For more Health articles, visit www.foxnews/health
“This is exciting because we are targeting the root cause of Parkinson’s and not the symptoms. It’s the first drug ever to take a patient from positive to negative.”
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
Some doctors, however, cautioned that Parkinson’s patients shouldn’t get their hopes up just yet.
“People with Parkinson’s should be aware that although the findings were interesting, this was only a safety, tolerability and immunogenicity study, and thus there is a long way to go for development of this treatment,” Michael S. Okun, M.D., Parkinson’s Foundation medical adviser and director at the Norman Fixel Institute for Neurological Diseases at the University of Florida Health, told Fox News Digital.
Okun was not involved in the study.
The injections did seem to “rev up the immune system,” Okun acknowledged, as the researchers observed the appearance of antibodies in the blood samples of most study participants.
“The worry that many scientists have about this approach is that it may neither improve clinical outcomes nor slow disease progression,” he added.
“Two similar antibody trials of prasinezumab and cinpanemab were published in 2022 in The New England Journal of Medicine, but both of those trials failed to meet their primary outcomes.”
Okun concluded that “time and science will help us to determine if this newer approach will fare better.”
Health
This Family Went Plant-Based and Lost 250 lbs — Here's the Plan That Can Help You Too
Sign Up
Create a free account to access exclusive content, play games, solve puzzles, test your pop-culture knowledge and receive special offers.
Already have an account? Login
Forgot your password?
Get back to the Sign In
Use left and right arrow keys to navigate between menu items.
Use escape to exit the menu.
-
News1 week ago
NYC pastor is sentenced to 9 years for fraud, including taking a single mom's $90,000
-
News1 week ago
Read the Ruling by the Virginia Court of Appeals
-
News7 days ago
Tracking a Single Day at the National Domestic Violence Hotline
-
Politics1 week ago
Trump classified docs judge to weigh alleged 'unlawful' appointment of Special Counsel Jack Smith
-
News7 days ago
Supreme Court upholds law barring domestic abusers from owning guns in major Second Amendment ruling | CNN Politics
-
Crypto1 week ago
Factors Driving the Evolution of Cryptocurrency Markets
-
Politics7 days ago
Supreme Court upholds federal gun ban for those under domestic violence restraining orders
-
News1 week ago
Opinion: Extreme heat kills. What the US can do to protect the most vulnerable | CNN